Useful Resources—For When You Need More
Discover how Orenitram provides clinical intervention for when patients need improvement in key measures of risk.1-3*
*2022 guidelines define measures of risk as 6MWD, FC, and NT-proBNP.4
Orenitram Titration Kit
See how the Orenitram Titration Kit may guide your patient through the first 3 months of their treatment journey.
Hear From PAH Experts
Discussion of FREEDOM-EV Trial
Hear the principal investigator of FREEDOM-EV, R. James White, MD, PhD, discuss the trial’s background and important outcomes.
Right Heart Function in FREEDOM-EV
Learn about the impact of Orenitram on right heart function in the FREEDOM-EV trial from Paul Forfia, MD.
Measuring Risk and the Impact of Orenitram
See the effect that Orenitram had on several key risk parameters—as well as overall risk status—in FREEDOM-EV with Jean Elwing, MD.
Dosing and AE Management as a Team
Listen to Franck Rahaghi, MD, and Starlet Harrimon, RN, as they discuss how risk assessment measures and planning for expected adverse effects can help guide treatment with Orenitram.
Additional Support Resources
Take advantage of iAssist, a centralized hub for Orenitram that helps initiate, facilitate, and simplify the referral process.
Cost and Financial Support
See how United Therapeutics may help with cost assistance and support for patients taking Orenitram.
Discover how a United Therapeutics Virtual Patient Educator may help your patients get started on Orenitram.